Predictive value of amino acids in the treatment of major depression with fluvoxamine

Neuropsychobiology

Volumn 44, Issue 3, 2001, Pages 134-138

  Mauri, Massimo C ^a,d   Boscati, Luigi ^a   Volonteri, Lucia S ^a   Scalvini, Marta E ^a   Steinhilber, Clara P C ^a   Laini, Valerio ^b   Zamberlan, Federica ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b BUSTO ARSIZIO HOSPITAL   (Italy)

^c General Hospital   (Italy)

^d Clinical Neuropsychopharmacology Unit   (Italy)

Author keywords

Amino acids; Fluvoxamine; Major depression

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; FLUVOXAMINE; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE MARKER; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; MALE; MEDICAL ASSESSMENT; MELANCHOLIA; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; RATING SCALE; THROMBOCYTE; TREATMENT OUTCOME;

ADULT; AGED; AMINO ACIDS; ANALYSIS OF VARIANCE; BLOOD PLATELETS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0035741997     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054933     Document Type: Article

References (32)

1. The biochemistry of affective disorders
2. The catecholamine hypothesis of affective disorders: A review of supporting evidence
3. Comparison between zimelidine and desipramine in endogenous depression
4. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs
5. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders
6. 3-MHPG as a non-predictor of antidepressant response to imipramine and electroconvulsive therapy
7. Differentiation of psychotic from nonpsychotic depression by a biological marker
8. Plasma and platelet excitatory amino acids in psychiatric disorders
9. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression
10. Plasma and platelet amino acids profile in major depression
11. Relapse of depression after rapid depletion of tryptophan
12. The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder
13. Increased cerebrospinal fluid glutamine levels in depressed patients
14. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier
15. Neutral amino acids in the brain: Changes in response to food ingestion
16. Plasma neutral amino acids associated with the efficacy of antidepressant treatment, a summary
17. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements
18. The assessment of anxiety states by rating
19. A rating scale of depression
20. Platelets as peripheral models for neuropsychiatry: A brief review
21. Plasma and platelet amino acids in major depressed patients treated with fluvoxamine
22. Relationship between blood serotonergic variables, melancholic traits and response to antidepressant treatments
23. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients
24. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression
25. Decreased plasma tryptophan levels in major depression
26. Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression
27. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor
28. Plasma tryptophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depression
29. Predictive value of tryptophan/large neutral amino acids ratio to antidepressant response